Breast Cancer Clinical Trial
Official title:
Breast Cancer Screening and Follow-Up in a PBRN: The Mammography FastTrack Trial
RATIONALE: Screening may help doctors find breast cancer cells early and plan better
treatment for breast cancer. The Mammography FastTrack program may be effective in
increasing the number of patients who undergo mammography.
PURPOSE: This randomized clinical trial is studying the use of a Mammography FastTrack
program to increase the number of women who undergo mammography.
OBJECTIVES:
- Classify all patients within the Massachusetts General Primary Care-Practice Based
Research Network (MGPC-PBRN) according to patient-primary care provider (PCP) linkage
status.
- Develop a breast cancer screening intervention program called Mammography FastTrack
that facilitates the ordering of mammograms to be used either by PCPs (for PCP-linked
patients) or by practice managers (for practice-linked patients).
- Compare the impact of the Mammography FastTrack program on mammography screening rates
in PCP-linked vs practice-linked patients overdue for breast cancer screening.
OUTLINE: This is a randomized, multicenter study.
Mammography-eligible women are linked to either a provider or a practice within the
Massachusetts General Primary Care Practice-Based Research Network (MGPC-PBRN). Practices
within the MGPC-PBRN are stratified according to baseline mammography screening rates (high
vs low) and practice type (community health center vs hospital-based vs community-based) and
are randomized to 1 of 2 arms.
- Arm I: Physicians and practice managers receive e-mail alerts at months 1 and 3
informing them of the availability of mammography screening data for their panel of
primary-care patients. A hyperlink refers the provider to a web-portal for the
Mammography FastTrack program that lists all eligible patients who have not undergone
mammography. The provider may then click a button to schedule, defer (providing reason
for deferral), or provide the date of a recent mammogram.
- Arm II: Practices continue standard care. At the end of 12 months, electronic report
and billing data and a review of electronic health records are used to determine the
completion of mammograms.
PROJECTED ACCRUAL: A total of 6,730 patients will be accrued for this study.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |